SAIL recognised with 8 Prestigious PRSI National Awards for Communication Excellence (See 'Corp Brief') LoI signed to establish Centre of Excellence for CRISPR Innovation and Translation (See 'Corp Brief') Sonowal calls for integration of Modern Education and Spiritual Values (See 'Corp Brief') PMLA - Provisional attachments under Section 5 of PMLA can be initiated without chargesheet under Section 173 of CrPC, based on sufficient material: HC (See 'Legal Desk') Chouhan meets Rozgar Sahayaks (See 'Corp Brief') DRDO & RRU ink MoU to foster collaboration in research, education & training (See 'Corp Brief') IPR - By mapping claims of suit patent against each element of defendants' product, plaintiffs have established strong prima facie case demonstrating infringement of suit patent: HC (See 'Legal Desk') EVs driving India's Next Growth Story: MoS (See 'Corp Brief') Meditation is scientific tool for stress management and neuroplasticity: Experts (See 'Corp Brief') Misc - Directors of company under winding up are statutorily bound under Section 454 of Companies Act, to make full and accurate disclosure of assets: HC (See 'Legal Desk') Mandaviya leads 1st Anniversary Celebrations of Fit India Sundays on Cycle in Puducherry (See 'Corp Brief') MoHUA launches 10th Swachh Survekshan (See 'Corp Brief') Misc - Once CIRP is initiated, all claims against corporate debtor must be routed through insolvency process: HC (See 'Legal Desk') Centre releases grants of Rs 94 Crores for PRIs in Uttarakhand (See 'Corp Brief') New Logo for RRBs signifying single and unified brand identity unveiled (See 'Corp Brief') PMVBRY aims to incentivise creation of over 3.5 crore jobs over 2 years (See 'Corp Brief') IPR - Pharmaceutical guidelines illustrate that if combination of two prior art documents fails to provide result as claimed in invention in question, then teaching of prior art documents is considered to be teaching away: HC (See 'Legal Desk') Ministry of Parliamentary Affairs transforming functioning into paperless ecosystem (See 'Corp Brief') Scindia chairs review meeting on Matabari Tourism Circuit Development in Tripura (See 'Corp Brief') IPR - If Novartis had consciously waived its right to cross-examination by electing to file rebuttal evidence, there are no valid grounds to challenge Controller's order: HC (See 'Legal Desk') WHO Global Summit on Traditional Medicine Commences in New Delhi (See 'Corp Brief') MoS delivers national statement at UN on outcomes of World Summit on the Information Society (See 'Corp Brief') PM MITRA Parks anchored in 5F vision generating huge investment interest (See 'Corp Brief') IPR - While assessing 'prior art', mere similarity is insufficient and visual distinction matters, and for prior art to invalidate design, it must be clearly established and comparable in relevant features: HC (See 'Legal Desk') Steps taken to strengthen security of cyber ecosystem (See 'Corp Brief') ICG Ship Sarthak makes Strategic Port Call at Chabahar (See 'Corp Brief') IPR - On being satisfied that brand or mark has acquired status which is well known, there ought to be order directing that no individuals should be allowed to register UPI Ids or VPAs with said brand names: HC (See 'Legal Desk') CCI okays acquisition of paper & pulp manufacturing business of ABREL by ITC Ltd (See 'Corp Brief') CCI okays acquisition of equity stake in Logisteed Holdings, Ltd. by Japan Post Co., Ltd. (See 'Corp Brief') CCI nod to proposed combination involving acquisition of minority shareholding in DCX Global Limited by Coinbase Global Inc. (See 'Corp Brief') IBC - Compromise between bank and co-guarantor did not extinguish liability of other guarantors, who issued separate, enforceable undertakings: HC (See 'Legal Desk')

Print

LoI signed to establish Centre of Excellence for CRISPR Innovation and Translation

Published: Dec 23, 2025

By TIOLCorplaws News Service

NEW DELHI, DEC 23, 2025: A new Letter of Intent (LoI) has been signed to establish a new Centre of Excellence for CRISPR Innovation and Translation (CoE-CIT) as a dedicated hub to harness cutting-edge CRISPR technologies to facilitate translation of scientific discoveries in a laboratory into real-world clinical applications.

The Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru an autonomous institute of Department of Science and Technology (DST) and CRISPRBITS Private Limited (CrisprBits) based in Delhi, focused on Biotechnology using CRISPR gene-editing technology for developing affordable diagnostics, has announced the signing of a Letter of Intent (LOI) to jointly establish the CoE-CIT, in a landmark public–private partnership between academia and industry which is among the first of its kind in India.

The CoE-CIT is envisioned to bridge the bench to bed gap leading and have therapeutic impact by combining JNCASR's strengths in fundamental biomedical sciences with CrisprBits' expertise in applied gene-editing and translational platforms. Demonstrating how Indian scientific innovation can be effectively translated into societal and clinical benefit, the CoE will serve as a replicable national model for academic–industry partnerships to strengthen India's biotechnology and innovation ecosystem.

"It is an exciting landmark event for JNCASR to plan this CoE on its campus partnering with CRISPRBITS, known for building intelligent molecular platforms for development of scalable, affordable innovative solutions in health sciences. Synergizing the mutual strengths in genetics, molecular and chemical biology, and computational biology, this unique partnership will open a new route to impact society and national missions," says Umesh Waghmare, President of JNCASR.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.